<code id='5EA755B524'></code><style id='5EA755B524'></style>
    • <acronym id='5EA755B524'></acronym>
      <center id='5EA755B524'><center id='5EA755B524'><tfoot id='5EA755B524'></tfoot></center><abbr id='5EA755B524'><dir id='5EA755B524'><tfoot id='5EA755B524'></tfoot><noframes id='5EA755B524'>

    • <optgroup id='5EA755B524'><strike id='5EA755B524'><sup id='5EA755B524'></sup></strike><code id='5EA755B524'></code></optgroup>
        1. <b id='5EA755B524'><label id='5EA755B524'><select id='5EA755B524'><dt id='5EA755B524'><span id='5EA755B524'></span></dt></select></label></b><u id='5EA755B524'></u>
          <i id='5EA755B524'><strike id='5EA755B524'><tt id='5EA755B524'><pre id='5EA755B524'></pre></tt></strike></i>

          explore

          explore

          author:explore    Page View:5
          Photography of the US department of health and human services in Silver Spring MD
          Manuel Balce Ceneta/AP

          An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

          Triple-check your data or we’ll reject your device, the FDA warned.

          advertisement

          The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more
          Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.
          Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Close Medicare's dangerous gaps in addiction treatment coverage

          YUKIIWAMURA/AFPviaGettyImagesWhilemanypeopleimmediatelypictureyoungadultswhenthinkingaboutthecurrent